Suspected Aortic Dissection in a Patient with a Prior Contrast Reaction and Reduced Renal Function

The study should proceed now; waiting 13 hours is not acceptable.

• Why premedication cannot be the priority: the standard 13-hour oral regimen (prednisone 50 mg at 13, 7 and 1 hour plus diphenhydramine 50 mg) only reduces the frequency and severity of reactions - breakthrough reactions still occur - and it cannot be completed in a patient whose aorta may rupture. A type A dissection can progress in hours; delay trades a small, manageable allergy risk for a much larger risk of death.
• Reassess the prior reaction: urticaria plus wheeze is a moderate reaction, not anaphylactic shock or airway compromise, which lowers the expected severity of a repeat event.
• What to do instead: call the radiologist and ED attending to the scanner, give IV methylprednisolone 32 mg and IV diphenhydramine 50 mg as partial prophylaxis, and prepare for a breakthrough reaction: epinephrine 1 mg/mL drawn up, oxygen, suction, airway cart, albuterol, IV crystalloid, and a nurse dedicated to monitoring the patient. Observe for at least 30 minutes after injection. Document the indication, the prior reaction, and the decision.

An injection at 4–5 mL/s through a 22-gauge hand vein is not acceptable: hand veins are small, mobile and poorly tolerant of high flow, and extravasation in a patient who may need thrombolysis or surgery creates a limb-threatening problem.

• Preferred: a second, larger line - 18-gauge (or 20-gauge) in the antecubital fossa or forearm, placed by the most experienced person available, with ultrasound guidance if needed.
• If no large peripheral site exists: consider an ultrasound-guided basilic or brachial vein, or, in a truly unstable patient, intraosseous or central access coordinated with the ED.
• If only the 22-gauge is available: reduce the flow rate to about 2–2.5 mL/s, use a lower-concentration contrast with a saline chaser, and use bolus tracking on the descending aorta to time the acquisition, accepting somewhat lower arterial opacification. Check patency with a saline test injection first.
• Safety checks: confirm the catheter is rated for the pressure used, watch the site for the first 15 seconds of injection, and stop immediately at any pain or swelling.

eGFR 34 should not change the decision. The feared complication is contrast-associated acute kidney injury, which at this level of function after intravenous contrast is uncommon and usually transient; no prophylaxis (bicarbonate, N-acetylcysteine, hours of pre-hydration) has been shown to prevent it, and none is worth delaying a study for a possible aortic dissection.

• Metformin: current guidance is to continue metformin when eGFR is at least 30 mL/min/1.73 m²; hold it and recheck renal function at 48 hours only when eGFR is below 30 or there is acute kidney injury. At 34, no interruption is required, though local policy may differ.
• Risk reduction that does not cost time: use the smallest contrast volume that still gives diagnostic opacification (weight-based, roughly 1 mL/kg to a maximum around 100–120 mL), avoid a second contrast study within 48–72 hours, and give isotonic crystalloid if the patient is not in heart failure.
• Documentation: record the baseline creatinine and eGFR, the discussion with the requesting team, and the plan to recheck renal function.